Cargando…

Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity

The amyloid precursor protein (APP) is a key player in Alzheimer`s disease (AD) and the precursor of the Aβ peptide, which is generated by consecutive cleavages of β- and γ-secretases. Familial Alzheimer’s disease (FAD) describes a hereditary subgroup of AD that represents a low percentage of AD cas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schilling, Sandra, Pradhan, Ajay, Heesch, Amelie, Helbig, Andrea, Blennow, Kaj, Koch, Christian, Bertgen, Lea, Koo, Edward H., Brinkmalm, Gunnar, Zetterberg, Henrik, Kins, Stefan, Eggert, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234039/ https://www.ncbi.nlm.nih.gov/pubmed/37259128 http://dx.doi.org/10.1186/s40478-023-01577-y

Ejemplares similares

Shedding of APP limits its synaptogenic activity and cell adhesion properties
por: Stahl, Ronny, et al.
Publicado: (2014)

Synaptogenic effect of APP-Swedish mutation in familial Alzheimer’s disease
por: Zhou, Bo, et al.
Publicado: (2022)

Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
por: Sjödin, Simon, et al.
Publicado: (2016)

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
por: Sjödin, Simon, et al.
Publicado: (2017)

The Rab5 activator RME-6 is required for amyloid precursor protein endocytosis depending on the YTSI motif
por: Eggert, Simone, et al.
Publicado: (2020)

Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments
por: Wild, Klemens, et al.
Publicado: (2017)

Heteromers of amyloid precursor protein in cerebrospinal fluid
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2015)

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
por: Sjödin, Simon, et al.
Publicado: (2019)

The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
por: Öhrfelt, Annika, et al.
Publicado: (2016)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
por: Duits, Flora H., et al.
Publicado: (2018)

Abundant Expression of Guidance and Synaptogenic Molecules in the Injured Spinal Cord
por: Jacobi, Anne, et al.
Publicado: (2014)

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
por: Minta, Karolina, et al.
Publicado: (2021)

Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer’s Disease Patients
por: Lopez-Font, Inmaculada, et al.
Publicado: (2022)

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry
por: Camporesi, Elena, et al.
Publicado: (2022)

γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
por: Weber, Tobias A., et al.
Publicado: (2021)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
por: Brinkmalm, Ann, et al.
Publicado: (2014)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments
por: Grant, Marianne K. O., et al.
Publicado: (2019)

APP family member dimeric complexes are formed predominantly in synaptic compartments
por: Schilling, Sandra, et al.
Publicado: (2023)

The DISC1 Pathway Modulates Expression of Neurodevelopmental, Synaptogenic and Sensory Perception Genes
por: Hennah, William, et al.
Publicado: (2009)

Differential Expressions of Synaptogenic Markers between Primary Cultured Cortical and Hippocampal Neurons
por: Kim, Yun-Gi, et al.
Publicado: (2012)

Alternative splicing at neuroligin site A regulates glycan interaction and synaptogenic activity
por: Oku, Shinichiro, et al.
Publicado: (2020)

Differential Properties of the Synaptogenic Activities of the Neurexin Ligands Neuroligin1 and LRRTM2
por: Dagar, Sushma, et al.
Publicado: (2019)

Structural aspects and physiological consequences of APP/APLP trans-dimerization
por: Baumkötter, Frederik, et al.
Publicado: (2011)

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
por: Kvartsberg, Hlin, et al.
Publicado: (2018)

Molecular forms of neurogranin in cerebrospinal fluid
por: Nazir, Faisal Hayat, et al.
Publicado: (2020)

Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides
por: Hanbouch, Linda, et al.
Publicado: (2022)

Fluid Biomarkers for Synaptic Dysfunction and Loss
por: Camporesi, Elena, et al.
Publicado: (2020)

The novel synaptogenic protein Farp1 links postsynaptic cytoskeletal dynamics and transsynaptic organization
por: Cheadle, Lucas, et al.
Publicado: (2012)

Synaptogenic activity of the axon guidance molecule Robo2 underlies hippocampal circuit function
por: Blockus, Heike, et al.
Publicado: (2021)

APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
por: Isbert, Simone, et al.
Publicado: (2011)

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method
por: Öhrfelt, Annika, et al.
Publicado: (2011)

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
por: Sjölander, Annica, et al.
Publicado: (2010)

The best-laid plans go oft awry: synaptogenic growth factor signaling in neuropsychiatric disease
por: Williams, Aislinn J., et al.
Publicado: (2014)

Autism-associated variants of neuroligin 4X impair synaptogenic activity by various molecular mechanisms
por: Yumoto, Takafumi, et al.
Publicado: (2020)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
por: Selnes, Per, et al.
Publicado: (2010)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
por: Minta, Karolina, et al.
Publicado: (2020)

APP Protein Family Signaling at the Synapse: Insights from Intracellular APP-Binding Proteins
por: Guénette, Suzanne, et al.
Publicado: (2017)

The effects of different familial Alzheimer’s disease mutations on APP processing in vivo
por: Thordardottir, Steinunn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qo9dvfli1v5cklrd310auimpl2